PRIA Healthcare News and Insights
From Reimbursement to Resource Allocation: How the Rules for Med Tech Adoption are Being Rewritten
Stop Guessing What FDA Wants
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
You Got Your 510(k). Now What?
Right Sizing Your Quality System
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
